Biotechnology

New patent for the Aerie Pharms ROCKLATAN drug – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published in New patent for Aerie Pharms’ ROCKLATAN drug


Annual Drug Patent Expiration for ROCKLATAN

Rocklatan is a drug marketed by Aerie Pharms Inc and included in one NDA. It is available from a single supplier. There are fifteen patents protecting this drug.

ROCKLATAN drug price trends.

This drug has sixty patent family members in eleven countries.

The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. One registered supplier for this compound. Additional details are available on latanoprost; netarsudil dimesylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in New patent for Aerie Pharms’ ROCKLATAN drug



Source link

Related Articles

Back to top button